Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma

Learn how to leverage immune checkpoint inhibitors for optimal management of HCC across different settings with expert-authored slides and an on-demand Webcast capturing a dynamic live CCO Webinar.

Share

Program Content

Activities

Immunotherapy in HCC
Immunotherapy in Hepatocellular Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2020

Expires: October 13, 2021

First-Line IO in HCC
IO Combinations in First-line Advanced HCC: Current Evidence and Ongoing Trials
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2020

Expires: October 13, 2021

IO in Early HCC
IO Combinations in Early or Intermediate-Stage HCC: Current Evidence and Ongoing Trials
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2020

Expires: October 13, 2021

<i>EP</i>: IO in HCC
ExpressPoints: Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2020

Expires: October 25, 2021

Activities

Immunotherapy in HCC
Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2020

Expires: October 25, 2021

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca